Rhodes Jason P's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Jun 26, 2026
- Accession no.
- 0001577014-26-000010
- Filed
- Jun 26, 2026
- Trade date
- Jun 23-25, 2026
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.65M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rhodes Jason PCIK 0001577014 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Common Stock | SSaleDisposed | −77,855 | $21.13 | −$1,645,076.15 | 4,805,639 | Indirect | |
| Jun 23, 2026 | Common Stock | SSaleDisposed | −39,131 | $21.13 | −$826,838.03 | 1,510,157 | Indirect | |
| Jun 23, 2026 | Common Stock | SSaleDisposed | −30,774 | $21.13 | −$650,254.62 | 1,106,036 | Indirect | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −50,530 | $21.02 | −$1,062,140.6 | 4,755,109 | Indirect | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −25,397 | $21.02 | −$533,844.94 | 1,484,760 | Indirect | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −19,973 | $21.02 | −$419,832.46 | 1,086,063 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −12,699 | $21.10 | −$267,948.9 | 4,742,410 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −6,382 | $21.10 | −$134,660.2 | 1,478,378 | Indirect | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −5,019 | $21.10 | −$105,900.9 | 1,081,044 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.